[Kidney transplantation from Maastricht III donors after circulatory death, overview of the situation in France]. / Transplantation rénale avec donneurs de la catégorie III de Maastricht, état des lieux en France.

Organ retrieval from deceased donors after controlled circulatory arrest improves access to kidney transplantation as a complement to brain dead donors. Authorised since 2014, they represent a real opportunity for patients awaiting a kidney transplant. The initial national results of the French protocol are encouraging.

[Organ and tissue donation after cessation of treatment in intensive care, the role of the nurse coordinator]. / Don d'organes et de tissus après arrêt des thérapeutiques en réanimation, rôle de la coordination infirmière.

Since the end of 2014 in France, it has been possible to remove organs after a process of cessation of active treatment. This new procedure requires rigorous and well-managed organisation, as well as close collaboration between all those involved in the care, notably in the coordination of organ and tissue procurement.

[Renal transplantation using a Maastricht category III non-heartbeating donor: First French experience and review of the literature]. / Transplantation rénale à partir d'un donneur décédé par arrêt circulatoire Maastricht III : première expérience française et revue de la littérature.

In 2015, Annecy Hospital was the first French hospital to perform non-heartbeating organ donation from a Maastricht category III donor (patient awaiting cardiac arrest after withdrawal of treatment). Non-heartbeating organ donation (NHBD), performed in France since 2006, had initially excluded this category, due to ethical questions concerning end of life and treatment withdrawal, as well as technical specificities linked to this procedure. Grenoble University Hospital and Edouard-Herriot Hospital in Lyon then performed the first kidney transplants, with satisfactory outcomes in both recipients. This article presents the details and results of this new experience, challenging both on a deontological and organizational level. Functional outcomes of kidney grafts from NHBD are now well known in the literature and confirm their benefit for patients, with similar results to those from heartbeating donors (HBD). International experiences concerning specifically Maastricht category III NHBD are encouraging and promising.